Videos Investors are learning that paying 20X sales is nothing if the growth numbers are right. Articles You May Like David Einhorn to speak as the priciest market in decades gets even pricier postelection 5 Stocks to Buy on a Trump Victory AI’s Dark Horse Could Become Its Crown Jewel Under Trump Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value